William Blair Starts LogicBio Therapeutics (LOGC) at Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. SPY
5. BA
6. STX
7. GOOGL
8. NOW
9. GOOG
10. V

Go back to William Blair Starts LogicBio Therapeutics (LOGC) at Outperform

Chardan Capital Markets Starts LogicBio Therapeutics (LOGC) at Buy

November 13, 2018 6:47 AM EST

Chardan Capital Markets analyst Gbola Amusa initiates coverage on LogicBio Therapeutics (NASDAQ: LOGC) with a Buy rating and a price target of $20.00.

The analyst comments "LogicBios pipeline reflects a focus on indications that play to its strengths. The advantage lies in indications where 1)... More

Barclays Starts LogicBio Therapeutics (LOGC) at Overweight

November 13, 2018 4:16 AM EST

Barclays analyst Gena Wang initiates coverage on LogicBio Therapeutics (NASDAQ: LOGC) with a Overweight rating and a price target of $24.00.

For an analyst ratings summary and ratings history on LogicBio Therapeutics click here. For more ratings news on LogicBio Therapeutics click here.

Shares of LogicBio Therapeutics closed at $13.72 yesterday.

... More